一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集

Abstract

Full Text of PDF Full Text of PDF (368k)  required ID / password
Article in Japanese

Original Article

Medical treatment for influenza inpatients and evaluation of anti-influenza agents at Takatsuki Red Cross Hospital

Kenichi Gotoa  Ayano Toriyamaa  Manabu Nomizoa  Koichi Hasegawaa  Hiroko Fukadaa  Yasukiyo Nakamuraa  Hideo Kitaa  Megumi Matsushitab 

aDepartment of Pulmonary Medicine, Takatsuki Red Cross Hospital
bInfection Control Section, Takatsuki Red Cross Hospital

ABSTRACT

Aim of this study is to evaluate the background and the effectiveness of anti-influenza agents for influenza inpatients. We collected information about inpatients diagnosed with influenza from November 2016 to April 2019 in our hospital from medical charts. In results, 188 inpatients (2016/2017: 58 patients, 2017/2018: 54 patients, 2018/2019: 76 patients) had been diagnosed with influenza. The medications prescribed comprised oseltamivir (50 patients), peramivir (95), zanamivir (two), laninamivir (five), and baloxavir marboxil (34). Two patients received no medication. One hundred and eighty patients had risk factors for influenza complications. Duration of fever after the prescription of anti-influenza agents (2.51±2.20 days), length of hospital stay (18.3±22.3 days), and mortality rate (16/188 patients) showed no significant differences between the groups when classified by anti-influenza agents. In conclusion, consistent with the previous reports, patients prescribed baloxavir marboxil showed no significant differences between the patients prescribed other anti-influenza agents in terms of duration of fever, length of hospitalization, or mortality rate.

KEYWORDS

Influenza  Inpatient  Baloxavir marboxil 

Received 23 Dec 2019 / Accepted 25 Mar 2020

AJRS, 9(4): 239-244, 2020

Google Scholar